B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma
CD79α (Dako Omnis)

- Monoclonal Mouse Anti-Human
No data to display
This product is not available for purchase by the general public.
Product Details
Features
- Optimized staining performance of both high and low-expression structures
- Dako Omnis and the dynamic gap staining technology provides a consistent, uniform staining with excellent morphology
- Crisp and clear staining with no background
- Optimal laboratory efficiency with ready-to-use antibodies on Dako Omnis
- The staining performance of all FLEX RTU antibodies has been defined, tested and approved through collaboration with leading, international pathology experts.
Specifications
| Application |
|
| Clone |
|
| Immunogen |
|
| Isotype |
|
| Reagent Provided |
|
| Solutions |
|
| Species |
|
| Specificity |
|
Literature
- Technical Overviews
-
Immunohistochemical Staining Methods - Education Guide, Sixth Edition
The focus of the sixth edition of the IHC Guidebook is to provide a comprehensive immunohistochemistry (IHC) resource for lab managers, lab technicians, learning pathologists, and students from around the world.
- Technical Overviews
- English
- 30 Nov 2021
- 27.05 MB
Support
- Material Safety Data Sheets
-
Products Containing Dako Antibody Diluent (Ab)
Material Safety Data Sheet
- Material Safety Data Sheets
- English
- 27 Aug 2025
- 127.42 KB
Featured References
- Product Description References
-
1. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K, et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995,86:1453-9.
2. Pilozzi E, Pulford K, Jones M, Muller-Hermelink HK, Falini B, Ralfkiaer E, et al. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol 1998,186:140-3.
3. Chu PG, Arber DA. CD79: a review. Appl Immunohistochem Mol Morphol 2001,9:97-106
Promotions